Table of Contents

Article

• Article

  p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas

  Jian-Zhong Qin, Lawrence Stennett, Patricia Bacon, Barbara Bodner, Mary J.C. Hendrix, Richard E.B. Seftor, Elisabeth A. Seftor, Naira V. Margaryan, Pamela M. Pollock, Amy Curtis, Jeffrey M. Trent, Frank Bennett, Lucio Miele and Brian J. Nickoloff

  Mol Cancer Ther August 1 2004 3 (8) 895-902;

  
  
• Article

  Characterization of inhibitors of specific carboxylesterases: Development of carboxylesterase inhibitors for translational application

  Kyoung Jin P. Yoon, Janice L. Hyatt, Christopher L. Morton, Richard E. Lee, Philip M. Potter and Mary K. Danks

  Mol Cancer Ther August 1 2004 3 (8) 903-909;

  
  
• Article

  The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer

  Terry Y-K. Chow, Moulay A. Alaoui-Jamali, Chiaoli Yeh, Leonard Yuen and David Griller

  Mol Cancer Ther August 1 2004 3 (8) 911-920;

  
  
• Article

  Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

  Daniel E.H. Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Susan M. Henshall, James G. Kench, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O'Hara, David Powers, Robert B. DuBridge, Ingrid Caras, Ruth Winter, Terri Anderson, Nanette Solvason, Phillip D. Stricker, Carlos Cordon-Cardo, Howard I. Scher, John J. Grygiel, Robert L. Sutherland, Richard Murray, Vanitha Ramakrishnan and Debbie A. Law

  Mol Cancer Ther August 1 2004 3 (8) 921-932;

  
  
• Article

  Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery

  Vaqar Mustafa Adhami, Moammir Hasan Aziz, Shannon R. Reagan-Shaw, Minakshi Nihal, Hasan Mukhtar and Nihal Ahmad

  Mol Cancer Ther August 1 2004 3 (8) 933-940;

  
  
• Article

  Polyomavirus middle T–induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes

  Jeannie E. Maglione, Erik T. McGoldrick, Lawrence J.T. Young, Ruria Namba, Jeffrey P. Gregg, Lin Liu, Drew Moghanaki, Lesley G. Ellies, Alexander D. Borowsky, Robert D. Cardiff and Carol L. MacLeod

  Mol Cancer Ther August 1 2004 3 (8) 941-953;

  
  
• Article

  Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells

  Mikael Rinne, David Caldwell and Mark R. Kelley

  Mol Cancer Ther August 1 2004 3 (8) 955-967;

  
  
• Article

  Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti–vascular endothelial growth factor receptor-2 antibody

  Alexander L. Rakhmilevich, Andrea T. Hooper, Daniel J. Hicklin and Paul M. Sondel

  Mol Cancer Ther August 1 2004 3 (8) 969-976;

  
  
• Article

  Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model

  David Raben, Cataldo Bianco, Vincenzo Damiano, Roberto Bianco, Davide Melisi, Chiara Mignogna, Francesco Paolo D'Armiento, Luca Cionini, A. Raffaele Bianco, Giampaolo Tortora, Fortunato Ciardiello and Paul Bunn

  Mol Cancer Ther August 1 2004 3 (8) 977-983;

  
  
• Article

  Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells

  Anupama Munshi, John F. Kurland, Takashi Nishikawa, Paul J. Chiao, Michael Andreeff and Raymond E. Meyn

  Mol Cancer Ther August 1 2004 3 (8) 985-992;

  
  
• Article

  Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets

  Cathrine M. Holland, Samir A. Saidi, Amanda L. Evans, Andrew M. Sharkey, John A. Latimer, Robin A.F. Crawford, D. Stephen Charnock-Jones, Cristin G. Print and Stephen K. Smith

  Mol Cancer Ther August 1 2004 3 (8) 993-1001;

  
  
• Article

  Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation

  Liang Liu, Joel B. Berletch, Jessica G. Green, Mitchell S. Pate, Lucy G. Andrews and Trygve O. Tollefsbol

  Mol Cancer Ther August 1 2004 3 (8) 1003-1009;

  
  
• Article

  Retinoid X receptor-γ and peroxisome proliferator-activated receptor-γ expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment

  Joshua P. Klopper, William R. Hays, Vibha Sharma, Margaret A. Baumbusch, Jerome M. Hershman and Bryan R. Haugen

  Mol Cancer Ther August 1 2004 3 (8) 1011-1020;